Safe pennies??

[enlyten]

CTEI ( .05 ) Cemtrex Information to Be Available Through Standard & Poor's Market Access Program
FARMINGDALE, N.Y., Feb. 23 /PRNewswire-FirstCall/ -- Cemtrex Inc. (OTC: CTEI - News) announced today that its company information will be made available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight. The company information to be made available through this program includes share price, volume, dividends, shares outstanding, company financial position, and earnings. Standard & Poor's Advisor Insight is an Internet-based research engine used by more than 100,000 investment advisors.

[Swany]

Braden will be back as Mod as soon as he can

[braden]

VIAP

[navyvet]

Looks like a good call so far, as long as .001 support doesnt fall on this right now it could run some more. .001 support looks to be key. If the support falls of .001 though, i see a major retrace back to 7's. Longs will need to hold it there.

[TITAN]

It bottomed now...eom

[navyvet]

ALTU, after hours trading up to .26. Alot of the people who wanted to sell on this news probably did IMO. This is defiantly a risk buy, but could rebound partially as soon as tomorrow. I hope it does just that. IMO if you dont get greedy here, at some point tuesday you could see a 30 percent return on this. But you know i just throw my opinion on things up here.

[braden]

Maybe today I screw up maybe not.
Went in big with ALTU at .24 I also went in big with GORX after they announced simular news and that paid off nicely.Hope for the same turn around.

[braden]

SSCC..Smurfit-Stone seeks bankruptcy protection
Smurfit-Stone Container files for Chapter 11 bankruptcy protection, looks to restructure debt
Mike Obel, AP Manufacturing Writer
Monday January 26, 2009, 9:35 am EST

[braden]

Not a penny but F at 1.80 after a huge eod drop,look for a nice bounce.

[braden]

IMRX,,NTRO,,MMTC,,VIAP

[Padron]

Whats in play for tomorrow?

[navyvet]

Looks like some info should be coming out on VIAP about their phase two trial results sometime in early 2009. News is traded heavy on these things and usually bolt up afterwards. Could start to see a nice move on this.

"The Phase 2 FDG-PET trial is enrolling approximately 50 patients following a heart attack into a 24 week randomized, double blind, placebo-controlled study. Enrollment is expected to be complete during 2008 and data is expected in the first half of 2009. Endpoints in the study include reduction in plaque inflammation following dosing with VIA-2291 as measured with FDG-PET, as well as assessment of standard biomarker measurements of inflammation. The use of state-of-the art FDG-PET imaging technology provides a new and important methodology for measuring the effect of VIA-2291 in reducing vascular inflammation."

[braden]

Coming products for VIAP
http://www.viapharmaceuticals.com/product-pipeline/

[braden]

I know been there.Gonna get it before then

[navyvet]

if it passes have fun trying to catch it. These take off so fast its almost impossible to get your bid in.

[braden]

Still loving VIAP This one looks to have hit bottom.

[braden]

I agree.Also if it passes ...Whooo hoooo

[navyvet]

i have it under my watchlist also, intresting to see where this one will run to in time. Play the trials with this one, its almost a "sure" thing if you do.

[braden]

Ive been looking at past trials/pps runs and it looks like 3 to 4 weeks prior the pps starts inching up.Will have to keep a watch on it.
CYCC

[navyvet]

defiantly a stock to watch for good returns. Should be safe depending on what type of funding they have to get them through the trials. Once the trials are complete this will likely take off. IMO may take a little before a major take off. Intrest in the trials will produce trading, which should be good for shorter term profits on buying the dips and selling off on highs. Many of these type company's will have a 30% range that they trade from almost monthly. Can be very profitable to play these until closer to completion. I've done that with ORMP a while back and made a decent return with it.

[braden]

And here is a list you will find interesting...http://3.bp.blogspot.com/_Du0YWLylHeA/SRt6axvesLI/AAAAAAAAAS4/CBsNBYdgQGQ/s1600-h/fdac12nov08.JPG

[navyvet]

Here is a website for anyone intrested on the breakdown of each phase trial. There is three trials unfortuantely before products are released.

http://www.osteopenia3.com/clinical-trials.html

[braden]

Good reply navyvet,I thought the 2nd phase was the last one.

[navyvet]

If one of these products reach and pass phase three trials this stock will take off. I have seen drug companies like this complete phase three trials and take off on 2000% afterwards. They are still a ways off of phase three completion though. For that reason i believe IMO it will dip to 30 cents sometime this week. Alot of the recent hype lately is from the phase two trials beginning. There is always alot of hype for a company after the completion or beginning of any phase trial. This will lose a little of that hype until the announcement of completion of the phase two trials. Like the company and it is coming out with medication that can defiantly be successful. Still has a ways to go before i believe it will really take off though, since no drugs are ready to begin phase three trials yet. Very good pick for a solid drug company with the possiblity of going places when it completes all trials!

[navyvet]

"Cyclacel is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine (CYC682), a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes, cutaneous T-cell lymphoma and lung cancer. Seliciclib (CYC202 or R-roscovitine), a CDK (cyclin dependent kinase) inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer. CYC116, an Aurora kinase and VEGFR2 inhibitor, is in Phase 1 in patients with solid tumors. Several additional programs are at an earlier stage. Cyclacel’s ALIGN Pharmaceuticals subsidiary markets directly in the U.S. Xclair ® Cream for radiation dermatitis, Numoisyn™ Liquid and Numoisyn™ Lozenges for xerostomia. Cyclacel’s strategy is to build a diversified biopharmaceutical business focused in hematology, oncology and other therapeutic areas based on a portfolio of commercial products and a development pipeline of novel drug candidates."

[braden]

CYCC looks good for a run...http://www.cyclacel.com/
pps .36

[braden]

SSCC..Like it love it ..Good safe play right now.imo
Pps .06

[braden]

Winner winner chicken dinner....hahahahah good one.

[The GidDy uP Kid]

NCOA

Shares Float 70,800,000
Total Shares Outstanding 96,650,451
% Owned by Insiders 28.54 %

[navyvet]

thanks i will check this one out. Looks to have some potential to it.

[The GidDy uP Kid]

projected 2009 sales of .22/share

[The GidDy uP Kid]

NCOA getting some nice action
bid .003 ask .004
way undervalued here
pinks sheets has free level 2
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=ncoa#getQuote

[navyvet]

im trying to do some DD now on new companies right now. Does anybody have a stock thats looking good. Thoughts appreciated.

[braden]

Good call,I love the way this one is setting up.

[navyvet]

EESO has been hot lately. I would say it is a safe bet if you can get in at .0085 here. Solid support for the stock at these levels. Not sure what friday has in store (possible retrace) but i believe that monday will be a huge day for this. Said it at .002 here and still believe that it has more to come.

[enlyten]

up again ticker ctei

[enlyten]

cemtrex.com ticker CTEI

[Swany]

K

[Swany]

Why not, It could be REAL cheap labor.....LMAO. That keeps profit high and PPS right along with it. They are so close to being there, IMO, this could be a really great thing.

[braden]

Ive given it years!!!MAN,Im getting old here...Running out of time...LOL
Hey lets take this to chart players,maybe $D is hanging around..K

[Swany]

Plus, set your emotions aside about the "Guys", your one of my brothers, if I thought they were a scam I would tell you. They are real, and smart. All great things take some time.

[braden]

Nah I just paid again.Maybe for an established company but not a start up.Im open for a chane of mind but I dont like it as of now.

[Swany]

Dude, I know you are close to being out of posts, but this is really a great type of program, I work with a MULTI Billion $ company and we do something similar and it is really a huge success. Man, some kids are major hackers by the time they are 12. Why not bring them in?

[braden]

Exobox Announces Formation of Young Entrepreneur Program
College Interns Will Have Opportunity to Help Secure Info-centric Community

Exobox Technologies Corp. (OTCBB:EXBX) today announced that it has formed the Exobox Young Entrepreneur Internship Program, designed to give second- through fourth-year college students an opportunity to work side-by-side with world-renowned information security thought leaders on risk management solutions for the information-centric community.

The Exobox Young Entrepreneur Program, which is geared towards entrepreneur-minded students interested in information security, will provide real-world experience working in the research and development arm of a technology company, going well beyond traditional internships that often limit student involvement to entry-level tasks.

“Interns selected for the Exobox Young Entrepreneur Program will have a unique opportunity to contribute to the development of innovative technologies that, if validated by market need, have the potential for being commercialized,” said Exobox Chief Technology Officer Ted Ernst, who is spearheading the program.

Ernst said utilizing young talent such as college students can add an exciting dimension to technology research and development.

“Individuals who have not been exposed to full-time jobs in the industry frequently investigate creative avenues that have not been contemplated,” Ernst said. “The exchange of ideas between these bright, young minds and experienced technologists will often lead to cutting edge solutions, which will ultimately enhance Exobox’s ability to achieve its goal of creating a more secure environment for the info-centric community.”

[Swany]

The internship?

[Swany]

Then no, do you have a quick link for me?

[braden]

NO not captivi another one...

[Swany]

are you refering to captavi?

[Swany]

Not yet, I got in about an hour ago and trying to catch up on everything

[braden]

Hey buddy did you see the latest exbx pr??